These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14991601)

  • 1. Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection.
    Misslitz AC; Bonhagen K; Harbecke D; Lippuner C; Kamradt T; Aebischer T
    Eur J Immunol; 2004 Mar; 34(3):715-725. PubMed ID: 14991601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.
    Ramírez-Pineda JR; Fröhlich A; Berberich C; Moll H
    J Immunol; 2004 May; 172(10):6281-9. PubMed ID: 15128817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for Th1-dependent immunity against infection with Leishmania major.
    von Stebut E; Udey MC
    Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens.
    Berberich C; Ramírez-Pineda JR; Hambrecht C; Alber G; Skeiky YA; Moll H
    J Immunol; 2003 Mar; 170(6):3171-9. PubMed ID: 12626575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major.
    Schnitzer JK; Berzel S; Fajardo-Moser M; Remer KA; Moll H
    Vaccine; 2010 Aug; 28(36):5785-93. PubMed ID: 20615489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
    Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
    Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice.
    Nigg AP; Zahn S; Rückerl D; Hölscher C; Yoshimoto T; Ehrchen JM; Wölbing F; Udey MC; von Stebut E
    J Immunol; 2007 Jun; 178(11):7251-8. PubMed ID: 17513774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.
    Muraille E; De Trez C; Pajak B; Torrentera FA; De Baetselier P; Leo O; Carlier Y
    Infect Immun; 2003 May; 71(5):2704-15. PubMed ID: 12704145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice.
    De Trez C; Magez S; Akira S; Ryffel B; Carlier Y; Muraille E
    PLoS Pathog; 2009 Jun; 5(6):e1000494. PubMed ID: 19557162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice.
    Remer KA; Apetrei C; Schwarz T; Linden C; Moll H
    Eur J Immunol; 2007 Sep; 37(9):2463-73. PubMed ID: 17705130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
    Matos I; Mizenina O; Lubkin A; Steinman RM; Idoyaga J
    PLoS One; 2013; 8(6):e67453. PubMed ID: 23840706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
    Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.